Erratum: Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma (Proceedings of the National Academy of Sciences of the United States of America 109 (4503-4508) DOI: 10.1073/pnas.1121601109);Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 12, 2012, Pages 4503-4508

  Grant, Trevor J ^a   Bishop, Joshua A ^a,g   Christadore, BLisa M ^a   Barot, Girish ^a   Chin, Hang Gyeong ^b,c   Woodson, Sarah ^a   Kavouris, John ^a   Siddiq, Ayesha ^d   Gredler, Rachel ^d   Shen, Xue Ning ^d   Sherman, Jennifer ^a,e   Meehan, Tracy ^a   Fitzgerald, Kevin ^e   Pradhan, Sriharsa ^c   Briggs, Laura A ^f   Andrews, William H ^f   Sarkar, Devanand ^d   Schaus, Scott E ^a   Hansen, Ulla ^a,b  

^a Boston University   (United States)

^b BOSTON UNIVERSITY   (United States)

^c NEW ENGLAND BIOLABS   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ALNYLAM PHARMACEUTICALS   (United States)

^f GenNEXT Materials and Technologies   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

CP2; TFCP2; Transcription factor inhibitor; Xenograft tumor model

Indexed keywords

ANTINEOPLASTIC AGENT; FACTOR QUINOLINONE INHIBITOR 1; OCTAMER TRANSCRIPTION FACTOR 1; QUINOLINE DERIVATIVE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F3; TRANSCRIPTION FACTOR LSF; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL ACTIVITY; CELL ADHESION; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA BINDING; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IC 50; LIVER CELL; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION INITIATION; TUMOR VOLUME;

RODENTIA;

EID: 84858692193     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.2203330119     Document Type: Erratum

References (34)

1. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 132:2557-2576. (Pubitemid 46890874)
2. Farazi PA, DePinho RA (2006) Hepatocellular carcinoma pathogenesis: From genes to environment. Nat Rev Cancer 6:674-687. (Pubitemid 44286000)
3. Yau T, Chan P, Epstein R, Poon RT (2008) Evolution of systemic therapy of advanced hepatocellular carcinoma. World J Gastroenterol 14:6437-6441.
4. Tanaka S, Arii S (2009) Molecularly targeted therapy for hepatocellular carcinoma. Cancer Sci 100:1-8.
5. Llovet JM, Bruix J (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48:1312-1327.
6. Whittaker S, Marais R, Zhu AX (2010) The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 29:4989-5005.
7. Weinstein IB, Joe A (2008) Oncogene addiction. Cancer Res 68:3077-3080, discussion 3080.
8. Sharma SV, Settleman J (2010) Exploiting the balance between life and death: Targeted cancer therapy and "oncogenic shock". Biochem Pharmacol 80:666-673.
9. Yoo BK, et al. (2010) Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma. Proc Natl Acad Sci USA 107:8357-8362.
10. Fan R-H, Li J, Wu N, Chen P-S (2011) Late SV40 factor: A key mediator of Notch signaling in human hepatocarcinogenesis. World J Gastroenterol 17:3420-3430.
11. Traylor-Knowles N, et al. (2010) The evolutionary diversification of LSF and Grainyhead transcription factors preceded the radiation of basal animal lineages. BMC Evol Biol 10:101.
12. Swendeman SL, et al. (1994) Characterization of the genomic structure, chromosomal location, promoter, and development expression of the α-globin transcription factor CP2. J Biol Chem 269:11663-11671. (Pubitemid 24200393)
13. Hansen U, Owens L, Saxena UH (2009) Transcription factors LSF and E2Fs: Tandem cyclists driving G0 to S? Cell Cycle 8:2146-2151.
14. Saxena UH, et al. (2009) Phosphorylation by cyclin C/cyclin-dependent kinase 2 following mitogenic stimulation of murine fibroblasts inhibits transcriptional activity of LSF during G1 progression. Mol Cell Biol 29:2335-2345.
15. Powell CMH, Rudge TL, Zhu Q, Johnson LF, Hansen U (2000) Inhibition of the mammalian transcription factor LSF induces S-phase-dependent apoptosis by downregulating thymidylate synthase expression. EMBO J 19:4665-4675.
16. Bruni P, et al. (2002) Fe65, a ligand of the Alzheimer's β-amyloid precursor protein, blocks cell cycle progression by down-regulating thymidylate synthase expression. J Biol Chem 277:35481-35488.
17. Yoo BK, et al. (2009) Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 119:465-477.
18. Koehler AN (2010) A complex task? Direct modulation of transcription factors with small molecules. Curr Opin Chem Biol 14:331-340.
19. Venkatesan K, McManus HR, Mello CC, Smith TF, Hansen U (2003) Functional conservation between members of an ancient duplicated transcription factor family, LSF/Grainyhead. Nucleic Acids Res 31:4304-4316. (Pubitemid 37441791)
20. Kokoszynska K, Ostrowski J, Rychlewski L, Wyrwicz LS (2008) The fold recognition of CP2 transcription factors gives new insights into the function and evolution of tumor suppressor protein p53. Cell Cycle 7:2907-2915.
21. Zhong F, Swendeman SL, PopikW, Pitha PM, ShefferyM(1994) Evidence that levels of the dimeric cellular transcription factor CP2 play little role in the activation of the HIV-1 long terminal repeat in vivo or following superinfection with herpes simplex virus type 1. J Biol Chem 269:21269-21276.
22. Shirra MK, Hansen U (1998) LSF and NTF-1 share a conserved DNA recognition motif yet require different oligomerization states to form a stable protein-DNA complex. J Biol Chem 273:19260-19268. (Pubitemid 28366326)
23. Murata T, Nitta M, Yasuda K (1998) Transcription factor CP2 is essential for lens-specific expression of the chicken alphaA-crystallin gene. Genes Cells 3:443-457. (Pubitemid 28392200)
24. Li K, Foresee LN, Tunge JA (2005) Trifluoroacetic acid-mediated hydroarylation: Synthesis of dihydrocoumarins and dihydroquinolones. J Org Chem 70:2881-2883.
25. Vassilev LT, et al. (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303:844-848. (Pubitemid 38174664)
26. Haigh JA, Pickup BT, Grant JA, Nicholls A (2005) Small molecule shape-fingerprints. J Chem Inf Model 45:673-684. (Pubitemid 40795171)
27. Palli SR, Kapitskaya MZ, Kumar MB, Cress DE (2003) Improved ecdysone receptor-based inducible gene regulation system. Eur J Biochem 270:1308-1315. (Pubitemid 36384462)
28. Veljkovic J (2004) Role of the mammalian transcription factor LSF (late SV40 factor) in repression of DNA polymerase α gene expression. PhD dissertation (Boston University, Boston).
29. Cacioppo R (2008) Protein phosphatase 2A regulates phosphorylation of the transcription factor LSF in a cell growth-dependent manner. PhD dissertation (Boston University, Boston).
30. Rishi V, et al. (2005) A high-throughput fluorescence-anisotropy screen that identifies small molecule inhibitors of the DNA binding of B-ZIP transcription factors. Anal Biochem 340:259-271. (Pubitemid 40544865)
31. Waki K, et al. (2010) Establishment of functional telomerase immortalized human hepatocytes and a hepatic stellate cell line for telomere-targeting anticancer drug development. Cancer Sci 101:1678-1685.
32. Severgnini M, et al. (2011) A rapid two-step method for isolation of functional primary mouse hepatocytes: Cell characterization and asialoglycoprotein receptor based assay development. Cytotechnology 64:187-195.
33. Shea CM, Tzertzinis G (2010) Controlled expression of functional miR-122 with a ligand inducible expression system. BMC Biotechnol, 10.1186/1472-6750-10- 76.
34. Drouin EE, Schrader CE, Stavnezer J, Hansen U (2002) The ubiquitously expressed DNA-binding protein late SV40 factor binds Ig switch regions and represses class switching to IgA. J Immunol 168:2847-2856. (Pubitemid 34211664)